Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical and non-clinical formulations of paclitaxel produce qualitatively and quantitatively different peripheral neuropathy in rats and mice.

The journal of pain·2026
Same author

Barettin Suppresses Pancreatic Ductal Adenocarcinoma Proliferation via Topoisomerase IIα Inhibition.

Marine drugs·2026
Same author

Annulated cationic tetramethyl indo(di)carbocyanine dyes exhibit potent dark cytotoxicity in cancer cells.

Dyes and pigments : an international journal·2026
Same author

Inhibition of heat shock protein 90 in the mouse spinal cord enhances opioid antinociception through upregulation of PKCβ in CGRP neurons.

Pain·2026
Same author

Instant fluorescence lifetime imaging microscopy reveals mechano-metabolic reprogramming of stromal cells in breast peritumor microenvironment.

iScience·2026
Same author

Short- and Long-Term Effects of Social Isolation on Adult Murine Bone are Sex-Dependent.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 11, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

6.6K

Hsp90β-Selective Inhibitors: Probing the Solvent-Accessible Frontier.

Terin D'Amico1, Michael A Serwetnyk1, Xiaozheng Dou1

  • 1Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, 46556, USA.

Chemmedchem
|November 18, 2025
PubMed
Summary

Developing isoform-selective inhibitors targeting heat shock protein 90 beta (Hsp90β) offers a promising therapeutic strategy. This research explores structural modifications to enhance Hsp90β affinity and selectivity, overcoming limitations of previous pan-inhibitors.

Keywords:
ATP‐binding pocketanticancerhsp90binhibitor designoptimization

More Related Videos

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

3.2K
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.6K

Related Experiment Videos

Last Updated: Jan 11, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
07:57

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors

Published on: January 20, 2023

6.6K
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
06:51

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay

Published on: July 21, 2021

3.2K
Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
09:39

Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology

Published on: March 31, 2022

3.6K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Medicinal Chemistry

Background:

  • Heat shock protein 90 (Hsp90) inhibitors are investigated for cancer and neurological disorders.
  • Pan-inhibition of Hsp90 isoforms (Hsp90α and Hsp90β) leads to toxicity, hindering clinical applications.
  • Isoform-selective Hsp90 inhibitors are needed to improve therapeutic efficacy and reduce side effects.

Purpose of the Study:

  • To synthesize and evaluate novel Hsp90β-selective inhibitors.
  • To elucidate structure-activity relationships (SAR) for Hsp90β inhibitors.
  • To assess the in vitro and in cellulo efficacy of newly developed analogs.

Main Methods:

  • Synthesis of nineteen additional Hsp90β inhibitor analogs.
  • Evaluation of binding affinity and selectivity for cytosolic Hsp90 isoforms.
  • Structure-activity relationship analysis focusing on the solvent-exposed region.

Main Results:

  • Identified structural modifications that tolerate steric bulk and require specific heteroatoms for high Hsp90β affinity and selectivity.
  • Demonstrated selective inhibition of Hsp90β in cellulo with the synthesized compounds.
  • Established further SAR for Hsp90β-selective inhibitors.

Conclusions:

  • Subtle modifications in the solvent-exposed region significantly impact Hsp90 inhibitor affinity and selectivity.
  • The developed compounds show potential for selective Hsp90β inhibition.
  • This work supports the continued development of Hsp90 isoform-selective inhibitors for therapeutic use.